Chester County News and Community Website
BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced initial positive results from a pilot study of its pain management drug candidate, Probudur™. The study was conducted under an …
Virpax Pharmaceuticals Reports Promising Results in Probudur Pilot Study Read More BERWYN, PA — In a recent Special Meeting of Shareholders, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) revealed that its stockholders had given the green light for a reverse stock split. The …
Virpax Pharmaceuticals Shareholders Approve Reverse Stock Split Amid Nasdaq Compliance Efforts Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in non-opioid pain management therapies, has announced significant changes to its leadership team amidst ongoing litigation. The company recently …
Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman Read More BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX) has recently revealed its financial results for the third quarter ending September 30, 2023, alongside a series of significant developments.
Virpax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Announces New Developments Read More BERYWN, PA — In a significant move that promises to reshape the future of pain management, Virpax Pharmaceuticals, Inc. (NASDAQ: VRPX) recently announced its intent to submit an Investigational New …
Virpax Pharmaceuticals’ Envelta Set for Human Trials Following FDA Review: A Potential Game-Changer in Pain Management Read More